miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis
CE Condrat, DC Thompson, MG Barbu, OL Bugnar… - Cells, 2020 - mdpi.com
MicroRNAs (miRNAs) represent a class of small, non-coding RNAs with the main roles of
regulating mRNA through its degradation and adjusting protein levels. In recent years …
regulating mRNA through its degradation and adjusting protein levels. In recent years …
MicroRNA biogenesis pathways in cancer
S Lin, RI Gregory - Nature reviews cancer, 2015 - nature.com
MicroRNAs (miRNAs) are critical regulators of gene expression. Amplification and
overexpression of individual'oncomiRs' or genetic loss of tumour suppressor miRNAs are …
overexpression of individual'oncomiRs' or genetic loss of tumour suppressor miRNAs are …
Comprehensive analysis of microRNA (miRNA) in cancer cells
N Kanwal, OR Al Samarrai, HMH Al-Zaidi… - Cellular, Molecular …, 2023 - cmbr-journal.com
MicroRNAs (miRNA) are a group of small non-coding RNAs that regulate gene expression
at the RNA level. MicroRNAs have positive regulatory effects on protein translation …
at the RNA level. MicroRNAs have positive regulatory effects on protein translation …
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g
Abstract Methyltransferase-like 3 (METTL3) is involved in RNA metabolism through N6-
methyladenosine (m 6 A) modification. However, whether METTL3 participates in the …
methyladenosine (m 6 A) modification. However, whether METTL3 participates in the …
[HTML][HTML] MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer
Dysregulation of microRNAs (miRNAs) is involved in the initiation and progression of
several human cancers, including breast cancer (BC), as strong evidence has been found …
several human cancers, including breast cancer (BC), as strong evidence has been found …
The roles of the Let-7 family of MicroRNAs in the regulation of cancer stemness
Y Ma, N Shen, MS Wicha, M Luo - Cells, 2021 - mdpi.com
Cancer has long been viewed as a disease of normal development gone awry. Cancer stem-
like cells (CSCs), also termed as tumor-initiating cells (TICs), are increasingly recognized as …
like cells (CSCs), also termed as tumor-initiating cells (TICs), are increasingly recognized as …
The molecular basis of endothelial cell plasticity
E Dejana, KK Hirschi, M Simons - Nature communications, 2017 - nature.com
The endothelium is capable of remarkable plasticity. In the embryo, primitive endothelial
cells differentiate to acquire arterial, venous or lymphatic fates. Certain endothelial cells also …
cells differentiate to acquire arterial, venous or lymphatic fates. Certain endothelial cells also …
The imprinted H19 lncRNA antagonizes let-7 microRNAs
Abundantly expressed in fetal tissues and adult muscle, the developmentally regulated H19
long noncoding RNA (lncRNA) has been implicated in human genetic disorders and cancer …
long noncoding RNA (lncRNA) has been implicated in human genetic disorders and cancer …
Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
E Chirshev, KC Oberg, YJ Ioffe… - Clinical and translational …, 2019 - Springer
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in
various diseases including cancer. The miRNA let-7 (MIRLET7) family controls …
various diseases including cancer. The miRNA let-7 (MIRLET7) family controls …
[HTML][HTML] Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms
E Piskounova, C Polytarchou, JE Thornton… - Cell, 2011 - cell.com
Summary Lin28A and Lin28B selectively block the expression of let-7 microRNAs and
function as oncogenes in a variety of human cancers. Lin28A recruits a TUTase …
function as oncogenes in a variety of human cancers. Lin28A recruits a TUTase …